| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.77B | 103.42B | 101.43B | 99.94B | 93.85B | 80.79B |
| Gross Profit | 16.13B | 16.82B | 15.68B | 15.65B | 15.27B | 14.36B |
| EBITDA | 7.23B | 9.85B | 10.47B | 9.17B | 6.10B | 8.46B |
| Net Income | 2.52B | 1.20B | 2.00B | 1.11B | -1.68B | 1.32B |
Balance Sheet | ||||||
| Total Assets | 113.91B | 105.02B | 109.95B | 111.54B | 100.11B | 96.92B |
| Cash, Cash Equivalents and Short-Term Investments | 3.65B | 2.06B | 1.76B | 3.11B | 3.71B | 10.91B |
| Total Debt | 46.13B | 36.10B | 41.15B | 39.78B | 36.70B | 36.15B |
| Total Liabilities | 76.33B | 64.23B | 71.11B | 70.93B | 67.91B | 65.00B |
| Stockholders Equity | 36.71B | 39.93B | 37.93B | 39.72B | 31.43B | 31.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.24B | -3.45B | -3.14B | -1.26B | 1.72B |
| Operating Cash Flow | 0.00 | 10.76B | 1.73B | 2.97B | 4.88B | 5.08B |
| Investing Cash Flow | 0.00 | -4.55B | -3.13B | -5.05B | -5.44B | -2.37B |
| Financing Cash Flow | 0.00 | -6.06B | -138.00M | 1.25B | -940.00M | -2.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥164.16B | 8.82 | ― | 4.47% | 1.64% | 19.87% | |
75 Outperform | ¥216.93B | 15.63 | 7.50% | 5.39% | -1.82% | 23.07% | |
67 Neutral | ¥48.37B | 4.31 | ― | 0.99% | -0.22% | -2.98% | |
62 Neutral | ¥114.65B | 7.99 | ― | 3.30% | -1.91% | 7.52% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥11.61B | 10.00 | ― | 3.90% | 1.96% | -37.72% | |
54 Neutral | ¥320.25B | 247.83 | ― | 1.93% | <0.01% | -83.75% |